Secukinumab, An Anti-Interleukin-17A Monoclonal Antibody, Improves Physical Function, Quality of Life and Work Productivity in Patients with Active Psoriatic Arthritis: Results From a Phase 3, Randomized, Controlled Trial

Chadha, P., Strand, V, Mease, P., McInnes, I., Kirkham, B., Kavanaugh, A., Rahman, P., Nash, P., Pricop, L., Yuan, J., Richards, H. and Mpofu, S. (2015). Secukinumab, An Anti-Interleukin-17A Monoclonal Antibody, Improves Physical Function, Quality of Life and Work Productivity in Patients with Active Psoriatic Arthritis: Results From a Phase 3, Randomized, Controlled Trial. In: Internal Medicine Journal. , , (42-42). .

Author Chadha, P.
Strand, V
Mease, P.
McInnes, I.
Kirkham, B.
Kavanaugh, A.
Rahman, P.
Nash, P.
Pricop, L.
Yuan, J.
Richards, H.
Mpofu, S.
Title of paper Secukinumab, An Anti-Interleukin-17A Monoclonal Antibody, Improves Physical Function, Quality of Life and Work Productivity in Patients with Active Psoriatic Arthritis: Results From a Phase 3, Randomized, Controlled Trial
Proceedings title Internal Medicine Journal   Check publisher's open access policy
Journal name Internal Medicine Journal   Check publisher's open access policy
Publication Year 2015
Sub-type Published abstract
ISSN 1444-0903
Volume 45
Start page 42
End page 42
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: WoS Import
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Sun, 14 Jun 2015, 01:01:22 EST by System User